Review Article
Disease control and objective responsive rates in randomized phase II trials evaluating non-first-line chemotherapy for non-small cell lung cancer: a systematic review of 74 trials
Hiromi Matsumoto, Nobuyuki Horita, Kentaro Ito, Risa Ebina-Shibuya, Yu Hara, Nobuaki Kobayashi, Takeshi Kaneko